SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Julong Holding Ltd. engages in the business of investment holding activities. It provides intelligent integrated solutions to public utilities, enterprises, commercial, and multifamily properties. The company was founded by Jia Qi Hu on August 07, 2023 and is headquartered in Beijing, China.

Julong Holding Ltd. - Ordinary Shares - Class A

Julong Holding Ltd. is experiencing extreme price volatility and massive volume surges, driven by retail speculation around its low float and persistent short interest. Community sentiment is sharply divided between traders aggressively chasing parabolic gains and those warning of a potential pump-and-dump scheme, with many closely monitoring for possible regulatory intervention.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing renewed attention as investors pivot toward software names, buoyed by recent analyst upgrades and optimism regarding the long-term potential of the Vector AI ad-tech platform. Despite this fundamental bullish sentiment, the stock continues to face significant volatility and choppy price action, with many in the community debating whether the current valuation reflects its growth trajectory in gaming and AI infrastructure.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing intense intraday volatility as traders react to contradictory reports regarding ceasefire talks with Iran, fueling speculation that algorithms are aggressively hunting stop losses. The community remains deeply divided, with many calling the price action heavily manipulated while day traders focus on scalping the violent swings and debating the impact of ongoing geopolitical headlines on market stability.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as investors focus on massive short interest, market manipulation concerns, and the high-stakes anticipation of upcoming preliminary Q2 revenue results and global expansion news. While the stock experiences daily volatility due to aggressive short-selling and sector-wide biotech fluctuations, the community remains intensely focused on potential catalysts like Anktiva sales, upcoming regulatory milestones, and strategic partnerships.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

Biotech is seeing renewed investor interest as capital rotates away from overextended tech and AI themes, driving the SPDR S&P Biotech ETF to clean breakouts on heavy volume. The community is actively debating the sustainability of this sector-wide move, with many traders focused on identifying acquisition targets and playing binary clinical trial catalysts while monitoring broader market conditions.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is facing intense volatility following an expanded partnership announcement and a subsequent short-seller report that triggered aggressive put buying and institutional selling. While some investors see the pullback as a buying opportunity based on strong energy-to-AI fundamentals and a bolstered $25 billion Brookfield deal, others are concerned about potential supply chain bottlenecks and extended valuations.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is facing intense selling pressure and high volatility as investors react to macroeconomic headwinds, fueling a heated debate between retail bulls betting on long-term growth and bears capitalizing on consistent intraday price reversals. The community is sharply divided, with intense discussion around the stock's inability to hold gains, technical support levels, and the influence of institutional algorithms on recent price action.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending as investors react to a significant $550 million convertible debt offering, with many on social media debating whether the move signals institutional confidence or unnecessary dilution. While some traders are expressing frustration over the stock's long-term range-bound performance and management's capital allocation, others are actively scaling into positions, citing the potential for clinical trial readouts later in the year.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is rallying following internal reports of a transition to in-house AI chip manufacturing, coupled with the launch of its Muse Spark 1.1 model to directly challenge competitors in the AI space. The community is actively debating the sustainability of this move, with many traders focused on the technical breakout above key resistance levels while others remain skeptical of the aggressive capital expenditure required for long-term AI infrastructure.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is experiencing a significant selloff following the announcement of a new stablecoin consortium, Open USD, which is backed by major financial players. Investors are debating whether this new competition threatens Circle's market share or if the recent price decline represents an emotional overreaction and a long-term buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ligand Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) have crossed above the average analyst 12-month target price of $271.00, changing hands for $274.88/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down...

Ligand Pharmaceuticals Director Unloads 2,501 Shares  Should You Be Concerned?

Key PointsKozarich sold 2,501 common shares...

A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million

Key Points5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighted average price around $227.06 per share...

Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Insider Sells 5,000 Shares of Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) insider Andrew Reardon sold 5,000 shares of the business's stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $231.31, for a total transaction of $1,156,550.00. Following the completion of the...

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS lessened its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 33.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,342 shares of the biotechnology compan...

HC Wainwright Brokers Increase Earnings Estimates for LGND

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) - Stock analysts at HC Wainwright lifted their Q3 2026 earnings per share estimates for Ligand Pharmaceuticals in a research note...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of "Moderate Buy" from Analysts

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) has earned an average rating of "Moderate Buy" from the eight brokerages that are currently covering the company, Marketbeat...

HC Wainwright Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price

HC Wainwright boosted their target price on Ligand Pharmaceuticals from $243.00 to $289.00 and gave the company a "buy" rating in a research report on Thursday...

Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - Here's Why

Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - What's Next...

Moody Aldrich Partners LLC Has $3.70 Million Stock Holdings in Ligand Pharmaceuticals Incorporated $LGND

Moody Aldrich Partners LLC decreased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 24.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 19,581 shares of the biotechnology company's stock after selling 6,303 sha...

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

TVTX Stock On Track To Hit Near 20-Year Highs After Filspari Becomes The Only Approved FSGS Treatment

Equity

Neutral Sentiment

Yes, I'm a buyer

Just watching

No, I'm not interested

The highly anticipated ADR listing of SK Hynix ($SKHY) goes live today. Are you a buyer of the stock? Drop your long-term thesis in the comments.

SK Hynix ($SKHY) listing day is upon us - are you a buyer? 
 
Drop a comment with your strategy.

Stocktwits

SK Hynix Inc

) listing day is upon us - are you a buyer? 
 
Drop a comment with your strategy.

Feed

News

Sentiment

Earnings

Fundamentals

Info

LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Fundamentals

Latest LGND News